Tolvaptan Response in a Hyponatremic Newborn with Syndrome of Inappropriate Secretion of Antidiuretic Hormone
The use of tolvaptan to treat both euvolemic and hypervolemic hyponatremia has rapidly increased in recent years. However, data on its effects on children, especially newborns and infants, are limited. Here, we present a newborn who developed syndrome of inappropriate secretion of antidiuretic hormo...
Main Authors: | Cengiz Zeybek, Ali Dinç Bozat, Erhan Calisici, Ahmet Bolat, Belma Saygili Karagol |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Case Reports in Pediatrics |
Online Access: | http://dx.doi.org/10.1155/2021/9920817 |
Similar Items
-
Treatment with urea as an alternative to tolvaptan for the syndrome of inappropriate secretion of antidiuretic hormone
by: I. Gómez Valbuena, et al.
Published: (2014-07-01) -
Syndrome of Inappropriate Antidiuretic Hormone Secretion and Ibuprofen, a Rare Association to Be Considered: Role of Tolvaptan
by: Nathan Artom, et al.
Published: (2013-01-01) -
Response to clinical case report: treatment with urea as an alternative to tolvaptan for the syndrome of inappropriate secretion of antidiuretic hormone
by: Alejandro Santiago Pérez, et al.
Published: (2014-11-01) -
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to bortezomib in a light chain multiple myeloma. Treatment with tolvaptan
by: Agustín Carreño, et al.
Published: (2017-09-01) -
Unduly Enhanced Response to Tolvaptan in a Woman Showing Syndrome of Inappropriate Antidiuretic Hormone Secretion: An Investigation of Possible Causes
by: Marco Panfili, MD, et al.
Published: (2017-01-01)